Antibiotic choices for CA-MRSA infectionsBell, Edward A
As of June 2002, 8 VISA infections had been documented in patients in the US[5]. Vancomycin has a narrow spectrum of activity, restricted to most Gram-positive bacteria, and is the drug of choice for the treatment of (MRSA). The vancomycin MIC for MRSA is 1–2 mg/L for fully ...
1. Methicillin-resistant Staphylococcus aureus (MRSA)Current/Emerging Resistant Bacteria Infection Types Resistance Notes Methicillin-resistant Staphylococcus aureus“staph” (MRSA) Infections can range from skin and soft tissue infections (cellulitis, abscess), to urinary tract infections, osteomyelitis (bone...
Vancomycin, an antibiotic produced byStreptomyces orientalis, is poorly absorbed from the gastrointestinal tract and is usually given by intravenous injection. It is used for the treatment of serious staphylococcal infections caused by strains resistant to the various penicillins. Its use against MRSA le...
multidrug-resistant isolates, particularly in the subset of infections caused by MRSA; (2) emergence of highly virulent strains of MRSA in the community setting; and (3) lack of clinical data to reliably support the use of antibiotics containing VCM in the treatment of severe infections caused ...
Among these cases MRSA accounts for 43.2% of infections in those hospitalized [61]. Antibiotic agents vancomycin or daptomycin are usually the first-line treatment for MRSA bacteraemia and related infections. However, in case of severe infection, combined therapy with flucloxacillin is given for ...
PURPOSE: The purpose of this study was to evaluate risk factors for failure of antibiotic treatment within 30 days for uncomplicated skin infections of out... EL Conway,JA Sellick,K Kurtzhalts,... - 《Antimicrob Agents Chemother》 被引量: 5发表: 2017年 Is MRSA Coverage Necessary for All I...
The problem has become increasingly severe as the bacteria have developed a resistance to antibiotics. As result,health care providersare running out of options to treat patients suffering from antibiotic-resistant infections, like MRSA and strep, creating a dire need for alternative treatments and app...
"Daptomycin should provide a safe and effective alternative to vancomycin, clindamycin or linezolid for IV treatment of invasive MRSA skin infections. Concerns for vancomycin renal toxicity and clindamycin antibiotic resistance were not present. There was no evidence of daptomycin toxicity in the trial."...
Although the Johns Hopkins investigators stop short of advocating against prescribing antibiotics for uncomplicated MRSA skin infections, they call for studies that directly measure the benefit — if any — of drug therapy versus proper wound care. The best study, they say, would compare patients rec...